BioSapien is a Biotech company based in San Diego. It has raised $7.3M in total funding. Latest round: Series A.
BioSapien funding overview
BioSapien is a Biotech company based in San Diego. BioSapien has raised $7.3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for BioSapien runs through 2024; nothing later has been disclosed. Investors on record include SOSV, Hikma Ventures, Global Ventures, Golden Gate Ventures, Dara Holdings, RebelBio and 4 others. 10 distinct backers are named across the disclosed rounds.
BioSapien at a glance
Total raised
$7.3M
Latest round
Series A
Latest round date
December 2024
Industry
Biotech
Headquarters
San Diego
Notable investors
SOSV, Hikma Ventures, Global Ventures, Golden Gate Ventures, Dara Holdings, RebelBio, Microventures, Infinity Capital Ventures
Frequently asked about BioSapien funding
How much has BioSapien raised?
BioSapien has raised $7.3M in total disclosed funding across the rounds on record.
Who has invested in BioSapien?
SOSV, Hikma Ventures, Global Ventures, Golden Gate Ventures, Dara Holdings, RebelBio are named among the investors backing BioSapien.
What was the latest BioSapien funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is BioSapien based?
BioSapien is based in San Diego.
What sector does BioSapien operate in?
BioSapien is tracked under Biotech from San Diego, with $7.3M in disclosed funding.
When did BioSapien last raise?
The last disclosed BioSapien round closed in December 2024 at Series A.
BioSapien totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Diego below to benchmark round size and investor mix.
